Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 6:06 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 600,000 2.01% | -1,456,377 (-70.82%) | View |
| 2022-02-11 5:32 pm Unchanged | 13G | CONTRAFECT CORP COM CFRX | PFIZER INC PFE | 1,785,267 4.54% | 0 (Unchanged) | View |
| 2022-02-11 5:10 pm Unchanged | 13G | ESSA PHARMA INC EPIX | PFIZER INC PFE | 1,675,000 3.81% | 0 (Unchanged) | View |
| 2022-02-11 4:55 pm Sale | 13G | BIOATLA INC BCAB | PFIZER INC PFE | 1,372,052 3.88% | -866,038 (-38.70%) | View |
| 2022-02-11 4:26 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | PFIZER INC PFE | 2,991,522 9.13% | 2,991,522 (New Position) | View |
| 2022-02-11 4:06 pm Unchanged | 13G | WAVE LIFE SCIENCES LTD WVE | PFIZER INC PFE | 1,875,000 3.19% | 0 (Unchanged) | View |
| 2022-02-11 3:54 pm Sale | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | PFIZER INC PFE | 341,658 1.06% | -1,325,000 (-79.50%) | View |
| 2022-02-10 08:32 am Purchase | 13G | PFIZER INC PFE | VANGUARD GROUP INC | 465,274,925 8.29% | 17,316,178 (+3.87%) | View |
| 2022-01-31 5:59 pm Purchase | 13G | PFIZER INC PFE | BlackRock Inc. BLK | 409,985,645 7.3% | 13,012,133 (+3.28%) | View |
| 2021-11-19 4:02 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | PFIZER INC PFE | 2,411,575 5.75% | 2,411,575 (New Position) | View |
| 2021-09-20 4:25 pm Purchase | 13G | ARVINAS INC ARVN | PFIZER INC PFE | 3,457,815 6.6% | 3,457,815 (New Position) | View |
| 2021-09-17 4:27 pm Unchanged | 13D | CEREVEL THERAPEUTICS HOLD. INC CERE | PFIZER INC PFE | 27,349,211 18.9% | 0 (Unchanged) | View |
| 2021-09-17 4:17 pm Unchanged | 13D | ALLOGENE THERAPEUTICS INC ALLO | PFIZER INC PFE | 22,032,040 15.5% | 0 (Unchanged) | View |
| 2021-07-09 4:25 pm Purchase | 13G | SPERO THERAPEUTICS INC SPRO | PFIZER INC PFE | 2,362,348 7.37% | 2,362,348 (New Position) | View |
| 2021-07-09 4:16 pm Unchanged | 13D | CEREVEL THERAPEUTICS HOLD. INC CERE | PFIZER INC PFE | 27,349,211 19.4% | 0 (Unchanged) | View |
| 2021-03-25 4:17 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 2,056,377 7% | -86,995 (-4.06%) | View |
| 2021-02-12 6:37 pm Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | PFIZER INC PFE | 1,666,658 6.3% | 1,666,658 (New Position) | View |
| 2021-02-12 6:00 pm Purchase | 13G | BIOATLA INC BCAB | PFIZER INC PFE | 2,238,090 7% | 2,238,090 (New Position) | View |
| 2021-02-12 5:37 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 2,143,372 7.3% | -1,106,601 (-34.05%) | View |
| 2021-02-12 5:17 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | PFIZER INC PFE | 1,785,267 6.4% | 1,785,267 (New Position) | View |